The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during the forecast period 2024-2030.

Histone Deacetylase (HDAC) Inhibitors Market

North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Histone Deacetylase (HDAC) Inhibitors include 4SC, Acetylon Pharmaceuticals, Celleron Therapeutics, Chipscreen Biosciences, Chroma Therapeutics, CrystalGenomics, Curis, MEI Pharma and Mirati Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Histone Deacetylase (HDAC) Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Histone Deacetylase (HDAC) Inhibitors.

Report Scope

The Histone Deacetylase (HDAC) Inhibitors market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Histone Deacetylase (HDAC) Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Histone Deacetylase (HDAC) Inhibitors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Histone Deacetylase (HDAC) Inhibitors Market Report

Report Metric	Details
Report Name	Histone Deacetylase (HDAC) Inhibitors Market
Accounted market size in 2023	US$ 615.2 million
Forecasted market size in 2030	US$ 1223.2 million
CAGR	8.8%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Fatty Acid Hydroxamate Cyclic Peptide Benzamide
Segment by Application	Treatment of Malignant Tumors Chronic Disease Treatment Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	4SC, Acetylon Pharmaceuticals, Celleron Therapeutics, Chipscreen Biosciences, Chroma Therapeutics, CrystalGenomics, Curis, MEI Pharma, Mirati Therapeutics, Novartis, Onxeo, Repligen, TetraLogic
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Histone Deacetylase (HDAC) Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Histone Deacetylase (HDAC) Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Histone Deacetylase (HDAC) Inhibitors Market growing?

Ans: The Histone Deacetylase (HDAC) Inhibitors Market witnessing a CAGR of 8.8% during the forecast period 2024-2030.

What is the Histone Deacetylase (HDAC) Inhibitors Market size in 2030?

Ans: The Histone Deacetylase (HDAC) Inhibitors Market size in 2030 will be US$ 1223.2 million.

Who are the main players in the Histone Deacetylase (HDAC) Inhibitors Market report?

Ans: The main players in the Histone Deacetylase (HDAC) Inhibitors Market are 4SC, Acetylon Pharmaceuticals, Celleron Therapeutics, Chipscreen Biosciences, Chroma Therapeutics, CrystalGenomics, Curis, MEI Pharma, Mirati Therapeutics, Novartis, Onxeo, Repligen, TetraLogic

What are the Application segmentation covered in the Histone Deacetylase (HDAC) Inhibitors Market report?

Ans: The Applications covered in the Histone Deacetylase (HDAC) Inhibitors Market report are Treatment of Malignant Tumors, Chronic Disease Treatment, Others

What are the Type segmentation covered in the Histone Deacetylase (HDAC) Inhibitors Market report?

Ans: The Types covered in the Histone Deacetylase (HDAC) Inhibitors Market report are Fatty Acid, Hydroxamate, Cyclic Peptide, Benzamide

1 Histone Deacetylase (HDAC) Inhibitors Market Overview

1.1 Product Overview and Scope of Histone Deacetylase (HDAC) Inhibitors

1.2 Histone Deacetylase (HDAC) Inhibitors Segment by Type

1.2.1 Global Histone Deacetylase (HDAC) Inhibitors Market Value Comparison by Type (2024-2030)

1.2.2 Fatty Acid

1.2.3 Hydroxamate

1.2.4 Cyclic Peptide

1.2.5 Benzamide

1.3 Histone Deacetylase (HDAC) Inhibitors Segment by Application

1.3.1 Global Histone Deacetylase (HDAC) Inhibitors Market Value by Application: (2024-2030)

1.3.2 Treatment of Malignant Tumors

1.3.3 Chronic Disease Treatment

1.3.4 Others

1.4 Global Histone Deacetylase (HDAC) Inhibitors Market Size Estimates and Forecasts

1.4.1 Global Histone Deacetylase (HDAC) Inhibitors Revenue 2019-2030

1.4.2 Global Histone Deacetylase (HDAC) Inhibitors Sales 2019-2030

1.4.3 Global Histone Deacetylase (HDAC) Inhibitors Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Histone Deacetylase (HDAC) Inhibitors Market Competition by Manufacturers

2.1 Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Manufacturers (2019-2024)

2.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Histone Deacetylase (HDAC) Inhibitors Average Price by Manufacturers (2019-2024)

2.4 Global Histone Deacetylase (HDAC) Inhibitors Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Histone Deacetylase (HDAC) Inhibitors, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Histone Deacetylase (HDAC) Inhibitors, Product Type & Application

2.7 Histone Deacetylase (HDAC) Inhibitors Market Competitive Situation and Trends

2.7.1 Histone Deacetylase (HDAC) Inhibitors Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Histone Deacetylase (HDAC) Inhibitors Players Market Share by Revenue

2.7.3 Global Histone Deacetylase (HDAC) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Histone Deacetylase (HDAC) Inhibitors Retrospective Market Scenario by Region

3.1 Global Histone Deacetylase (HDAC) Inhibitors Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Histone Deacetylase (HDAC) Inhibitors Global Histone Deacetylase (HDAC) Inhibitors Sales by Region: 2019-2030

3.2.1 Global Histone Deacetylase (HDAC) Inhibitors Sales by Region: 2019-2024

3.2.2 Global Histone Deacetylase (HDAC) Inhibitors Sales by Region: 2025-2030

3.3 Global Histone Deacetylase (HDAC) Inhibitors Global Histone Deacetylase (HDAC) Inhibitors Revenue by Region: 2019-2030

3.3.1 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Region: 2019-2024

3.3.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Region: 2025-2030

3.4 North America Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Country

3.4.1 North America Histone Deacetylase (HDAC) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2019-2030)

3.4.3 North America Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Country

3.5.1 Europe Histone Deacetylase (HDAC) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Histone Deacetylase (HDAC) Inhibitors Sales by Country (2019-2030)

3.5.3 Europe Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Country

3.6.1 Asia Pacific Histone Deacetylase (HDAC) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Histone Deacetylase (HDAC) Inhibitors Sales by Country (2019-2030)

3.6.3 Asia Pacific Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Country

3.7.1 Latin America Histone Deacetylase (HDAC) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2019-2030)

3.7.3 Latin America Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Country

3.8.1 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales by Country (2019-2030)

3.8.3 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Histone Deacetylase (HDAC) Inhibitors Sales by Type (2019-2030)

4.1.1 Global Histone Deacetylase (HDAC) Inhibitors Sales by Type (2019-2024)

4.1.2 Global Histone Deacetylase (HDAC) Inhibitors Sales by Type (2025-2030)

4.1.3 Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Type (2019-2030)

4.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2019-2030)

4.2.1 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2019-2024)

4.2.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2025-2030)

4.2.3 Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Type (2019-2030)

4.3 Global Histone Deacetylase (HDAC) Inhibitors Price by Type (2019-2030)

5 Segment by Application

5.1 Global Histone Deacetylase (HDAC) Inhibitors Sales by Application (2019-2030)

5.1.1 Global Histone Deacetylase (HDAC) Inhibitors Sales by Application (2019-2024)

5.1.2 Global Histone Deacetylase (HDAC) Inhibitors Sales by Application (2025-2030)

5.1.3 Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Application (2019-2030)

5.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2019-2030)

5.2.1 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2019-2024)

5.2.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2025-2030)

5.2.3 Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Application (2019-2030)

5.3 Global Histone Deacetylase (HDAC) Inhibitors Price by Application (2019-2030)

6 Key Companies Profiled

6.1 4SC

6.1.1 4SC Corporation Information

6.1.2 4SC Description and Business Overview

6.1.3 4SC Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.1.4 4SC Histone Deacetylase (HDAC) Inhibitors Product Portfolio

6.1.5 4SC Recent Developments/Updates

6.2 Acetylon Pharmaceuticals

6.2.1 Acetylon Pharmaceuticals Corporation Information

6.2.2 Acetylon Pharmaceuticals Description and Business Overview

6.2.3 Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Product Portfolio

6.2.5 Acetylon Pharmaceuticals Recent Developments/Updates

6.3 Celleron Therapeutics

6.3.1 Celleron Therapeutics Corporation Information

6.3.2 Celleron Therapeutics Description and Business Overview

6.3.3 Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Product Portfolio

6.3.5 Celleron Therapeutics Recent Developments/Updates

6.4 Chipscreen Biosciences

6.4.1 Chipscreen Biosciences Corporation Information

6.4.2 Chipscreen Biosciences Description and Business Overview

6.4.3 Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Product Portfolio

6.4.5 Chipscreen Biosciences Recent Developments/Updates

6.5 Chroma Therapeutics

6.5.1 Chroma Therapeutics Corporation Information

6.5.2 Chroma Therapeutics Description and Business Overview

6.5.3 Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Product Portfolio

6.5.5 Chroma Therapeutics Recent Developments/Updates

6.6 CrystalGenomics

6.6.1 CrystalGenomics Corporation Information

6.6.2 CrystalGenomics Description and Business Overview

6.6.3 CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.6.4 CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Product Portfolio

6.6.5 CrystalGenomics Recent Developments/Updates

6.7 Curis

6.6.1 Curis Corporation Information

6.6.2 Curis Description and Business Overview

6.6.3 Curis Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Curis Histone Deacetylase (HDAC) Inhibitors Product Portfolio

6.7.5 Curis Recent Developments/Updates

6.8 MEI Pharma

6.8.1 MEI Pharma Corporation Information

6.8.2 MEI Pharma Description and Business Overview

6.8.3 MEI Pharma Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.8.4 MEI Pharma Histone Deacetylase (HDAC) Inhibitors Product Portfolio

6.8.5 MEI Pharma Recent Developments/Updates

6.9 Mirati Therapeutics

6.9.1 Mirati Therapeutics Corporation Information

6.9.2 Mirati Therapeutics Description and Business Overview

6.9.3 Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Product Portfolio

6.9.5 Mirati Therapeutics Recent Developments/Updates

6.10 Novartis

6.10.1 Novartis Corporation Information

6.10.2 Novartis Description and Business Overview

6.10.3 Novartis Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Novartis Histone Deacetylase (HDAC) Inhibitors Product Portfolio

6.10.5 Novartis Recent Developments/Updates

6.11 Onxeo

6.11.1 Onxeo Corporation Information

6.11.2 Onxeo Histone Deacetylase (HDAC) Inhibitors Description and Business Overview

6.11.3 Onxeo Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Onxeo Histone Deacetylase (HDAC) Inhibitors Product Portfolio

6.11.5 Onxeo Recent Developments/Updates

6.12 Repligen

6.12.1 Repligen Corporation Information

6.12.2 Repligen Histone Deacetylase (HDAC) Inhibitors Description and Business Overview

6.12.3 Repligen Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Repligen Histone Deacetylase (HDAC) Inhibitors Product Portfolio

6.12.5 Repligen Recent Developments/Updates

6.13 TetraLogic

6.13.1 TetraLogic Corporation Information

6.13.2 TetraLogic Histone Deacetylase (HDAC) Inhibitors Description and Business Overview

6.13.3 TetraLogic Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.13.4 TetraLogic Histone Deacetylase (HDAC) Inhibitors Product Portfolio

6.13.5 TetraLogic Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Histone Deacetylase (HDAC) Inhibitors Industry Chain Analysis

7.2 Histone Deacetylase (HDAC) Inhibitors Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Histone Deacetylase (HDAC) Inhibitors Production Mode & Process

7.4 Histone Deacetylase (HDAC) Inhibitors Sales and Marketing

7.4.1 Histone Deacetylase (HDAC) Inhibitors Sales Channels

7.4.2 Histone Deacetylase (HDAC) Inhibitors Distributors

7.5 Histone Deacetylase (HDAC) Inhibitors Customers

8 Histone Deacetylase (HDAC) Inhibitors Market Dynamics

8.1 Histone Deacetylase (HDAC) Inhibitors Industry Trends

8.2 Histone Deacetylase (HDAC) Inhibitors Market Drivers

8.3 Histone Deacetylase (HDAC) Inhibitors Market Challenges

8.4 Histone Deacetylase (HDAC) Inhibitors Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

4SC AG

Acetylon Pharmaceuticals

Celleron Therapeutics

Chipscreen Biosciences

List of Tables

Table 1. Global Histone Deacetylase (HDAC) Inhibitors Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Histone Deacetylase (HDAC) Inhibitors Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Histone Deacetylase (HDAC) Inhibitors Market Competitive Situation by Manufacturers in 2023

Table 4. Global Histone Deacetylase (HDAC) Inhibitors Sales (MT) of Key Manufacturers (2019-2024)

Table 5. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Histone Deacetylase (HDAC) Inhibitors Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Histone Deacetylase (HDAC) Inhibitors Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Histone Deacetylase (HDAC) Inhibitors Average Price (USD/MT) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Histone Deacetylase (HDAC) Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Histone Deacetylase (HDAC) Inhibitors, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Histone Deacetylase (HDAC) Inhibitors, Product Type & Application

Table 12. Global Key Manufacturers of Histone Deacetylase (HDAC) Inhibitors, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Histone Deacetylase (HDAC) Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Histone Deacetylase (HDAC) Inhibitors as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Histone Deacetylase (HDAC) Inhibitors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Histone Deacetylase (HDAC) Inhibitors Sales by Region (2019-2024) & (MT)

Table 18. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Region (2019-2024)

Table 19. Global Histone Deacetylase (HDAC) Inhibitors Sales by Region (2025-2030) & (MT)

Table 20. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Region (2025-2030)

Table 21. Global Histone Deacetylase (HDAC) Inhibitors Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Region (2019-2024)

Table 23. Global Histone Deacetylase (HDAC) Inhibitors Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Region (2025-2030)

Table 25. North America Histone Deacetylase (HDAC) Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2019-2024) & (MT)

Table 27. North America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2025-2030) & (MT)

Table 28. North America Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Histone Deacetylase (HDAC) Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Histone Deacetylase (HDAC) Inhibitors Sales by Country (2019-2024) & (MT)

Table 32. Europe Histone Deacetylase (HDAC) Inhibitors Sales by Country (2025-2030) & (MT)

Table 33. Europe Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Sales by Region (2019-2024) & (MT)

Table 37. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Sales by Region (2025-2030) & (MT)

Table 38. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Histone Deacetylase (HDAC) Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2019-2024) & (MT)

Table 42. Latin America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2025-2030) & (MT)

Table 43. Latin America Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Sales by Country (2019-2024) & (MT)

Table 47. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Sales by Country (2025-2030) & (MT)

Table 48. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Histone Deacetylase (HDAC) Inhibitors Sales (MT) by Type (2019-2024)

Table 51. Global Histone Deacetylase (HDAC) Inhibitors Sales (MT) by Type (2025-2030)

Table 52. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Type (2019-2024)

Table 53. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Type (2025-2030)

Table 54. Global Histone Deacetylase (HDAC) Inhibitors Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Histone Deacetylase (HDAC) Inhibitors Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Type (2019-2024)

Table 57. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Type (2025-2030)

Table 58. Global Histone Deacetylase (HDAC) Inhibitors Price (USD/MT) by Type (2019-2024)

Table 59. Global Histone Deacetylase (HDAC) Inhibitors Price (USD/MT) by Type (2025-2030)

Table 60. Global Histone Deacetylase (HDAC) Inhibitors Sales (MT) by Application (2019-2024)

Table 61. Global Histone Deacetylase (HDAC) Inhibitors Sales (MT) by Application (2025-2030)

Table 62. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Application (2019-2024)

Table 63. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Application (2025-2030)

Table 64. Global Histone Deacetylase (HDAC) Inhibitors Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Histone Deacetylase (HDAC) Inhibitors Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Application (2019-2024)

Table 67. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Application (2025-2030)

Table 68. Global Histone Deacetylase (HDAC) Inhibitors Price (USD/MT) by Application (2019-2024)

Table 69. Global Histone Deacetylase (HDAC) Inhibitors Price (USD/MT) by Application (2025-2030)

Table 70. 4SC Corporation Information

Table 71. 4SC Description and Business Overview

Table 72. 4SC Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 73. 4SC Histone Deacetylase (HDAC) Inhibitors Product

Table 74. 4SC Recent Developments/Updates

Table 75. Acetylon Pharmaceuticals Corporation Information

Table 76. Acetylon Pharmaceuticals Description and Business Overview

Table 77. Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 78. Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Product

Table 79. Acetylon Pharmaceuticals Recent Developments/Updates

Table 80. Celleron Therapeutics Corporation Information

Table 81. Celleron Therapeutics Description and Business Overview

Table 82. Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 83. Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Product

Table 84. Celleron Therapeutics Recent Developments/Updates

Table 85. Chipscreen Biosciences Corporation Information

Table 86. Chipscreen Biosciences Description and Business Overview

Table 87. Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 88. Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Product

Table 89. Chipscreen Biosciences Recent Developments/Updates

Table 90. Chroma Therapeutics Corporation Information

Table 91. Chroma Therapeutics Description and Business Overview

Table 92. Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 93. Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Product

Table 94. Chroma Therapeutics Recent Developments/Updates

Table 95. CrystalGenomics Corporation Information

Table 96. CrystalGenomics Description and Business Overview

Table 97. CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 98. CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Product

Table 99. CrystalGenomics Recent Developments/Updates

Table 100. Curis Corporation Information

Table 101. Curis Description and Business Overview

Table 102. Curis Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 103. Curis Histone Deacetylase (HDAC) Inhibitors Product

Table 104. Curis Recent Developments/Updates

Table 105. MEI Pharma Corporation Information

Table 106. MEI Pharma Description and Business Overview

Table 107. MEI Pharma Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 108. MEI Pharma Histone Deacetylase (HDAC) Inhibitors Product

Table 109. MEI Pharma Recent Developments/Updates

Table 110. Mirati Therapeutics Corporation Information

Table 111. Mirati Therapeutics Description and Business Overview

Table 112. Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 113. Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Product

Table 114. Mirati Therapeutics Recent Developments/Updates

Table 115. Novartis Corporation Information

Table 116. Novartis Description and Business Overview

Table 117. Novartis Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 118. Novartis Histone Deacetylase (HDAC) Inhibitors Product

Table 119. Novartis Recent Developments/Updates

Table 120. Onxeo Corporation Information

Table 121. Onxeo Description and Business Overview

Table 122. Onxeo Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 123. Onxeo Histone Deacetylase (HDAC) Inhibitors Product

Table 124. Onxeo Recent Developments/Updates

Table 125. Repligen Corporation Information

Table 126. Repligen Description and Business Overview

Table 127. Repligen Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 128. Repligen Histone Deacetylase (HDAC) Inhibitors Product

Table 129. Repligen Recent Developments/Updates

Table 130. TetraLogic Corporation Information

Table 131. TetraLogic Description and Business Overview

Table 132. TetraLogic Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 133. TetraLogic Histone Deacetylase (HDAC) Inhibitors Product

Table 134. TetraLogic Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Histone Deacetylase (HDAC) Inhibitors Distributors List

Table 138. Histone Deacetylase (HDAC) Inhibitors Customers List

Table 139. Histone Deacetylase (HDAC) Inhibitors Market Trends

Table 140. Histone Deacetylase (HDAC) Inhibitors Market Drivers

Table 141. Histone Deacetylase (HDAC) Inhibitors Market Challenges

Table 142. Histone Deacetylase (HDAC) Inhibitors Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Histone Deacetylase (HDAC) Inhibitors

Figure 2. Global Histone Deacetylase (HDAC) Inhibitors Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Histone Deacetylase (HDAC) Inhibitors Market Share by Type in 2023 & 2030

Figure 4. Fatty Acid Product Picture

Figure 5. Hydroxamate Product Picture

Figure 6. Cyclic Peptide Product Picture

Figure 7. Benzamide Product Picture

Figure 8. Global Histone Deacetylase (HDAC) Inhibitors Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Histone Deacetylase (HDAC) Inhibitors Market Share by Application in 2023 & 2030

Figure 10. Treatment of Malignant Tumors

Figure 11. Chronic Disease Treatment

Figure 12. Others

Figure 13. Global Histone Deacetylase (HDAC) Inhibitors Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Histone Deacetylase (HDAC) Inhibitors Market Size (2019-2030) & (US$ Million)

Figure 15. Global Histone Deacetylase (HDAC) Inhibitors Sales (2019-2030) & (MT)

Figure 16. Global Histone Deacetylase (HDAC) Inhibitors Average Price (USD/MT) & (2019-2030)

Figure 17. Histone Deacetylase (HDAC) Inhibitors Report Years Considered

Figure 18. Histone Deacetylase (HDAC) Inhibitors Sales Share by Manufacturers in 2023

Figure 19. Global Histone Deacetylase (HDAC) Inhibitors Revenue Share by Manufacturers in 2023

Figure 20. The Global 5 and 10 Largest Histone Deacetylase (HDAC) Inhibitors Players: Market Share by Revenue in 2023

Figure 21. Histone Deacetylase (HDAC) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 22. Global Histone Deacetylase (HDAC) Inhibitors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country (2019-2030)

Figure 24. North America Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country (2019-2030)

Figure 25. U.S. Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country (2019-2030)

Figure 28. Europe Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country (2019-2030)

Figure 29. Germany Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Region (2019-2030)

Figure 36. China Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Taiwan Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Indonesia Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Thailand Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Malaysia Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Philippines Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Latin America Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country (2019-2030)

Figure 47. Latin America Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country (2019-2030)

Figure 48. Mexico Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Brazil Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Argentina Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country (2019-2030)

Figure 52. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country (2019-2030)

Figure 53. Turkey Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. U.A.E Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. Global Sales Market Share of Histone Deacetylase (HDAC) Inhibitors by Type (2019-2030)

Figure 57. Global Revenue Market Share of Histone Deacetylase (HDAC) Inhibitors by Type (2019-2030)

Figure 58. Global Histone Deacetylase (HDAC) Inhibitors Price (USD/MT) by Type (2019-2030)

Figure 59. Global Sales Market Share of Histone Deacetylase (HDAC) Inhibitors by Application (2019-2030)

Figure 60. Global Revenue Market Share of Histone Deacetylase (HDAC) Inhibitors by Application (2019-2030)

Figure 61. Global Histone Deacetylase (HDAC) Inhibitors Price (USD/MT) by Application (2019-2030)

Figure 62. Histone Deacetylase (HDAC) Inhibitors Value Chain

Figure 63. Histone Deacetylase (HDAC) Inhibitors Production Process

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Distributors Profiles

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Slammed Pipette Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-38Q8327

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Cryogenic Laboratory Equipment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-6L8705

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Preparative Chromatography Systems Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-0C3712

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Thiocarboxylic Acid Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-15P8542

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions